Figure 4.

Forest plots depicted the estimated casual effects of each SNP within the HMGCR and APOB inhibition tools regarding VTE, DVT and PE. (A): (a) HMGCR inhibitor on VTE risk; (b) HMGCR inhibitor on DVT risk; (c) HMGCR inhibitor on PE risk. (B): (a) APOB inhibitor on VTE risk; (b) APOB inhibitor on DVT risk; (c) APOB inhibitor on PE risk. APOB = apolipoprotein B, DVT = deep vein thrombosis, HMGCR = 3-hydroxy-3-methylglutaryl-CoA reductase, PE = pulmonary embolism, SNP = single nucleotide polymorphism, VTE = venous thromboembolism.